培氟沙星和环丙沙星在实验性诱导的中性粒细胞减少豚鼠假单胞菌肺炎中的活性。
Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.
作者信息
Gordin F M, Hackbarth C J, Scott K G, Sande M A
出版信息
Antimicrob Agents Chemother. 1985 Apr;27(4):452-4. doi: 10.1128/AAC.27.4.452.
Abstract
Pefloxacin and ciprofloxacin are two new quinoline carboxylic acid derivatives that have activity in vitro against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa. Using a well-standardized model of Pseudomonas pneumonia in neutropenic guinea pigs, we tested the efficacy in vivo of these new agents. Both were highly effective in increasing survival and decreasing bacterial counts in the lungs of surviving animals. Pefloxacin and ciprofloxacin were significantly better (P less than 0.05) than aminoglycosides or beta-lactams tested in prior studies with this model, and they were as effective as combination therapy with aminoglycosides and beta-lactams. Resistance to either ciprofloxacin or pefloxacin did not emerge during the study period. Further studies with these drugs in the therapy of Pseudomonas sp. infections are warranted.
摘要
培氟沙星和环丙沙星是两种新型喹啉羧酸衍生物，它们在体外对包括铜绿假单胞菌在内的多种革兰氏阴性菌具有活性。我们使用中性粒细胞减少的豚鼠中标准化良好的铜绿假单胞菌肺炎模型，测试了这些新药的体内疗效。两者在提高存活率和降低存活动物肺部细菌数量方面都非常有效。在该模型的先前研究中，培氟沙星和环丙沙星显著优于（P小于0.05）所测试的氨基糖苷类或β-内酰胺类药物，并且它们与氨基糖苷类和β-内酰胺类药物联合治疗的效果相同。在研究期间未出现对环丙沙星或培氟沙星的耐药性。有必要对这些药物在治疗铜绿假单胞菌感染方面进行进一步研究。
相似文献
1
Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.培氟沙星和环丙沙星在实验性诱导的中性粒细胞减少豚鼠假单胞菌肺炎中的活性。
Antimicrob Agents Chemother. 1985 Apr;27(4):452-4. doi: 10.1128/AAC.27.4.452.
2
Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.中性粒细胞减少豚鼠铜绿假单胞菌肺炎的单药与联合抗生素治疗
J Infect Dis. 1984 Jun;149(6):980-5. doi: 10.1093/infdis/149.6.980.
3
Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.五种喹啉衍生物与用于口腔治疗的其他五种抗菌剂的体外活性比较
Eur J Clin Microbiol. 1984 Aug;3(4):333-8. doi: 10.1007/BF01977489.
4
Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia.环丙沙星、依诺沙星和氧氟沙星在实验性铜绿假单胞菌肺炎中的比较评价
Antimicrob Agents Chemother. 1986 Mar;29(3):395-9. doi: 10.1128/AAC.29.3.395.
5
Comparative activities of ciprofloxacin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.环丙沙星、替卡西林和妥布霉素对实验性铜绿假单胞菌肺炎的比较活性
Antimicrob Agents Chemother. 1984 Jul;26(1):1-4. doi: 10.1128/AAC.26.1.1.
6
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.八种新型喹诺酮类药物与萘啶酸的体外活性比较
J Antimicrob Chemother. 1986 Nov;18 Suppl D:1-20. doi: 10.1093/jac/18.supplement_d.1.
7
Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
J Antimicrob Chemother. 1994 Apr;33(4):837-44. doi: 10.1093/jac/33.4.837.
8
In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis.环丙沙星对沙眼衣原体临床分离株的体外活性。
Eur J Clin Microbiol. 1984 Aug;3(4):372. doi: 10.1007/BF01977501.
9
[Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
Pathol Biol (Paris). 1985 May;33(5):416-20.
10
The comparative in-vitro activity of pefloxacin.培氟沙星的体外比较活性。
J Antimicrob Chemother. 1986 Apr;17 Suppl B:1-10. doi: 10.1093/jac/17.suppl_b.1.
引用本文的文献
1
Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.发热性中性粒细胞减少症的抗菌治疗：药代动力学-药效学考虑。
Clin Pharmacokinet. 2013 Oct;52(10):869-83. doi: 10.1007/s40262-013-0086-1.
2
Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.聚乙二醇包被脂质体包裹的环丙沙星治疗大鼠肺炎克雷伯菌肺炎的疗效提高。
Antimicrob Agents Chemother. 2001 May;45(5):1487-92. doi: 10.1128/AAC.45.5.1487-1492.2001.
3
Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.铜绿假单胞菌和金黄色葡萄球菌中的喹诺酮耐药性。治疗期间的发展及临床意义。
Infection. 1994;22 Suppl 2:S111-21. doi: 10.1007/BF01793575.
4
Should Pseudomonas aeruginosa isolates resistant to one of the fluorinated quinolones be tested for the others? Studies with an experimental model of pneumonia.对一种氟喹诺酮耐药的铜绿假单胞菌分离株是否应该对其他氟喹诺酮进行检测？肺炎实验模型研究。
Antimicrob Agents Chemother. 1995 Mar;39(3):677-9. doi: 10.1128/AAC.39.3.677.
5
The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.药代动力学/药效学替代标志物对治疗结果的重要性。聚焦于抗菌药物。
Clin Pharmacokinet. 1995 Feb;28(2):143-60. doi: 10.2165/00003088-199528020-00005.
6
Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia.依诺沙星、氧氟沙星、氨苄西林和氯霉素治疗实验性流感嗜血杆菌肺炎的比较评价
Antimicrob Agents Chemother. 1987 Mar;31(3):417-20. doi: 10.1128/AAC.31.3.417.
7
Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats.环丙沙星和头孢他啶对肺炎克雷伯菌在体外及白细胞减少大鼠实验性肺炎中的抗菌活性比较
Antimicrob Agents Chemother. 1987 Nov;31(11):1809-15. doi: 10.1128/AAC.31.11.1809.
8
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.环丙沙星：抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.
9
Comparative efficacy of ciprofloxacin, ceftazidime and gentamicin, given alone or in combination, in a model of experimental septicemia due to Klebsiella pneumoniae in neutropenic mice.
Infection. 1988;16(1):49-53. doi: 10.1007/BF01646933.
10
The relative efficacies of tobramycin and ciprofloxacin against Pseudomonas aeruginosa in vitro and in normal and granulocytopenic mice.
Infection. 1988;16(1):58-62. doi: 10.1007/BF01646935.
本文引用的文献
1
[Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].培氟沙星（1589 RB）、萘啶酸和氟甲喹抗菌活性的比较（作者译）
Pathol Biol (Paris). 1982 Jun;30(6):394-7.
2
In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives.环丙沙星与其他新型含氟哌嗪基取代喹啉衍生物的体外活性比较。
Antimicrob Agents Chemother. 1984 Apr;25(4):518-21. doi: 10.1128/AAC.25.4.518.
3
Pharmacokinetics and tissue penetration of ciprofloxacin.环丙沙星的药代动力学及组织穿透性
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6. doi: 10.1128/AAC.24.5.784.
4
Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans.甲磺酸培氟沙星在小鼠、大鼠、犬、猴及人体内的吸收、分布、代谢转归及消除
Antimicrob Agents Chemother. 1984 Apr;25(4):463-72. doi: 10.1128/AAC.25.4.463.
5
[Structure-activity relationships in the quinolone group: antibacterial activity of two new compounds (author's transl)].喹诺酮类药物的构效关系：两种新化合物的抗菌活性（作者译）
Ann Microbiol (Paris). 1981 May-Jun;132(3):267-81.
6
Comparative activities of ciprofloxacin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.环丙沙星、替卡西林和妥布霉素对实验性铜绿假单胞菌肺炎的比较活性
Antimicrob Agents Chemother. 1984 Jul;26(1):1-4. doi: 10.1128/AAC.26.1.1.
7
Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.中性粒细胞减少豚鼠铜绿假单胞菌肺炎的单药与联合抗生素治疗
J Infect Dis. 1984 Jun;149(6):980-5. doi: 10.1093/infdis/149.6.980.
8
In-vitro studies with ciprofloxacin, a new 4-quinolone compound.使用新型4-喹诺酮化合物环丙沙星进行的体外研究。
J Antimicrob Chemother. 1984 Apr;13(4):333-46. doi: 10.1093/jac/13.4.333.
9
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.环丙沙星，一种对需氧菌和厌氧菌均有活性的喹诺酮羧酸化合物。
Antimicrob Agents Chemother. 1984 Mar;25(3):319-26. doi: 10.1128/AAC.25.3.319.
10
In vitro activity of ciprofloxacin (Bay o 9867).环丙沙星（拜耳o 9867）的体外活性。
Antimicrob Agents Chemother. 1983 Oct;24(4):568-74. doi: 10.1128/AAC.24.4.568.
Zotero 插件